Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high-dimensional molecular profiles pose challenges to data interpretation and hypothesis generation. ActivePathways is an integrative method that discovers significantly enriched pathways across multiple datasets using statistical data fusion, rationalizes contributing evidence and highlights associated genes. As part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumor types, we integrated genes with coding and non-coding mutations and revealed frequently mutated pathways and additional cancer genes with infrequent mutations. We also analyzed pr...
Integration of multi-omics data from different molecular levels with clinical data, as well as epide...
Integration of multi-omics data from different molecular levels with clinical data, as well as epide...
<div><p>The study of cancer, a highly heterogeneous disease with different causes and clinical outco...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Since response to therapy can differ greatly between cancer patients, a precision medicine approach ...
Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivit...
<div><p>Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to inse...
Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivit...
Integration of multi-omics data from different molecular levels with clinical data, as well as epide...
Integration of multi-omics data from different molecular levels with clinical data, as well as epide...
<div><p>The study of cancer, a highly heterogeneous disease with different causes and clinical outco...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high...
Since response to therapy can differ greatly between cancer patients, a precision medicine approach ...
Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivit...
<div><p>Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to inse...
Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivit...
Integration of multi-omics data from different molecular levels with clinical data, as well as epide...
Integration of multi-omics data from different molecular levels with clinical data, as well as epide...
<div><p>The study of cancer, a highly heterogeneous disease with different causes and clinical outco...